Vikram Bhinder, MD
Neurocritical Care · Cleveland, OHNPI 1528475688
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $562 of the $750 with a category attached, or 74.9%. 7 manufacturers reported payments, led by AstraZeneca at 41.6% of the total. Reporting peaked in 2024 at $204 and has fallen 83.3% since, to $34 in 2025.
Across 21 payments — averaging $35.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$312
- Irras USA, Inc.$168
- UCB, Inc.$96
- Haemonetics Corporation$64
- CSL Behring$46
- Chiesi USA, Inc.$44
- plus $19 from 1 others
What the payments were for
- Speaking & faculty fees$16822%
- Food & beverage$56275%
- Education$203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 6 | $312 |
| Irras USA, Inc. | 1 | $168 |
| UCB, Inc. | 6 | $96 |
| Haemonetics Corporation | 1 | $64 |
| CSL Behring | 3 | $46 |
| Chiesi USA, Inc. | 3 | $44 |
| Merck | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$750 in reported general payments places this provider in the 60th percentile of 30 neurocritical care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Cleveland
- Sherief BossCleveland$5K
- Sydney MoseleyCleveland$1K
- Brittany BoltCleveland$211
- Agnieszka ArdeltCleveland$68
- Adam BarronCleveland$57
- Shweta GoswamiCleveland$15
- Michel TorbeyColumbus$18K
- John KachorisCincinnati$6K
- Amit ChaudhariToledo$6K
- Steven PlatkoMontgomery$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.